Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease

Haemophilia. 2016 Jul;22(4):564-9. doi: 10.1111/hae.12900. Epub 2016 Feb 4.

Abstract

Introduction: von Willebrand disease (VWD) is the most common inherited bleeding disorder. The age of bleeding onset is highly variable, also in patients with similar degree of severity.

Aim: The primary aim of this study was to evaluate whether baseline factor VIII (FVIII) plasma levels correlate with age at first bleeding in patients with extremely low levels of VWF:RCo (<6 IU dL(-1) ).

Methods: One hundred and three patients with VWF:RCo <6 IU dL(-1) (6 VWD1, 73 VWD2 and 24 VWD3) undergoing a medical examination between September 2010 and September 2013 were included. The relationship between baseline FVIII levels and age at first bleeding was tested in a multivariable linear regression model, adjusting for sex.

Results: The median age at first bleeding was lower in patients with VWD3 than in those with severe forms of VWD1 or VWD2 (1 year vs. 7 and 8 years, respectively, P < 0.0001). A positive non-linear relationship between FVIII levels and age at first bleeding was found, the latter increasing by 5 years for every 10 IU dL(-1) increase of FVIII (β = 4.95 [95% CI: 2.02-7.87]) until levels of 30 IU dL(-1) , after which the age increased slowly. This relationship was not found in VWD 2A and 2B. In 65 patients (63%) there was a more than 6-month delay between bleeding onset and VWD diagnosis, with no difference over decades.

Conclusions: Baseline FVIII plasma levels influence the age at bleeding onset in VWD patients with extremely low levels of VWF:RCo, except in those with types 2A and 2B.

Keywords: bleeding; blood coagulation disorders; factor VIII; von Willebrand disease; von Willebrand factor.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Antifibrinolytic Agents / therapeutic use
  • Blood Transfusion
  • Child
  • Child, Preschool
  • Factor VIII / analysis*
  • Female
  • Hemorrhage
  • Humans
  • Linear Models
  • Male
  • Severity of Illness Index
  • Young Adult
  • von Willebrand Disease, Type 1 / blood
  • von Willebrand Disease, Type 1 / pathology
  • von Willebrand Disease, Type 2 / blood
  • von Willebrand Disease, Type 2 / pathology
  • von Willebrand Disease, Type 3 / blood
  • von Willebrand Disease, Type 3 / pathology
  • von Willebrand Diseases / blood
  • von Willebrand Diseases / pathology*
  • von Willebrand Diseases / therapy
  • von Willebrand Factor / analysis

Substances

  • Antifibrinolytic Agents
  • von Willebrand Factor
  • Factor VIII